We sought to understand the basis of age-induced mitochondrial dysfunction, using the budding yeast, *S. cerevisiae.* Ageing in yeast (replicative ageing) is defined as the number of times an individual cells divides^[@R4]^, and aged yeast cells exhibit many characteristics of age-induced mitochondrial dysfunction observed in metazoa^[@R1]^. These include mitochondrial fragmentation, increased levels of mitochondrial reactive oxygen species (ROS), and increased loss of mitochondrial DNA in their progeny^[@R6]--[@R9]^. We began our inquiry by further characterizing age-associated mitochondrial phenotypes using a genetic system in yeast that enriches for replicatively-aged mother cells, the Mother Enrichment Program (MEP)^[@R10]^. By monitoring a fluorescently tagged outer mitochondrial membrane protein, Tom70-GFP, we found that mitochondrial dysfunction was prevalent in aged yeast, consistent with results from earlier studies^[@R6]^. Normally tubular mitochondria fragmented and ultimately aggregated in aged cells ([Fig. 1a](#F1){ref-type="fig"}). Mitochondrial fragmentation was present early in the ageing process (86% of cells at 8 divisions), and progressed to large aggregates and small fragments (93% of cells at 17 divisions) that persisted throughout ageing (median lifespan of 28 divisions). We observed similar changes using an inner mitochondrial membrane protein, Tim50-GFP ([Supplementary Fig. 2a](#SD1){ref-type="supplementary-material"}). Mitochondrial function also declined in aged cells. We measured the mitochondrial membrane potential (ΔΨ) of aged cells using DiOC~6~, a ΔΨ-dependent mitochondrial fluorescent dye^[@R11]^, and found that 80% of cells had reduced mitochondrial DiOC~6~ staining by 7 divisions ([Supplementary Fig. 2b](#SD1){ref-type="supplementary-material"}). At 18 divisions, ΔΨ was even lower and remained low thereafter (100% of cells by 28 divisions). Consistent with this, ΔΨ-dependent import of the mitochondrial matrix chimeric protein preCox4-mCherry^[@R9]^ was also reduced in aged cells ([Supplementary Fig. 2c](#SD1){ref-type="supplementary-material"}). Collectively, these results indicate that mitochondrial structure and function are progressively altered during the ageing process.

Mitochondrial structure is regulated by \~250 genes in young cells^[@R12],[@R13]^. We hypothesized that age-induced mitochondrial dysfunction might result from altered function of processes associated with one or more of these gene products. To explore this idea, we overexpressed each of the 250 genes in a MEP strain expressing Tom70-GFP, and screened for genes whose overexpression delayed the onset of altered mitochondrial morphology in aged cells. Two suppressors identified in our screen, *VMA1* and *VPH2*, are required for activity of the Vacuolar H^+^-ATPase (V-ATPase). The V-ATPase is an evolutionarily conserved protein complex that acidifies the vacuole (lysosome in metazoa)^[@R5]^. Vma1 is the catalytic subunit of the peripheral membrane associated V~1~ sector of the V-ATPase^[@R14]^. Vph2 is an ER-localized integral membrane protein required for V-ATPase assembly^[@R15]^. Overexpression of *VMA1* or *VPH2* from a high-copy promoter suppressed age-induced mitochondrial dysfunction in 93 or 77% of aged cells, respectively (17 or 16 divisions) ([Fig. 1b](#F1){ref-type="fig"} and [Supplementary Fig. 3a](#SD1){ref-type="supplementary-material"}). Importantly, suppression by *VMA1* or *VPH2* overexpression required V-ATPase activity, as treatment with the specific V-ATPase inhibitor, concanamycin A (concA)^[@R16]^, blocked their ability to produce normal, tubular mitochondria ([Fig. 1b](#F1){ref-type="fig"} and [Supplementary Fig. 3a](#SD1){ref-type="supplementary-material"}). Because overexpressing proteins required for vacuolar acidity prevented age-induced mitochondrial dysfunction, we tested if vacuolar pH itself was changed in aged cells. Measurement of vacuolar acidity with four different pH-sensitive reporters revealed that the acidity of the vacuole decreased as unbudded cells became experienced mother cells ([Fig. 2a, b](#F2){ref-type="fig"} and [Supplementary Fig. 4a, b, c](#SD1){ref-type="supplementary-material"}). Vacuoles in over 90% of young unbudded cells were acidic and stained efficiently with the fluorescent dye quinacrine, which accumulates in acidic environments^[@R17]^ ([Fig. 2a](#F2){ref-type="fig"} and [Supplementary Fig. 4a](#SD1){ref-type="supplementary-material"}). However, 87% of cells which had produced daughters had decreased vacuolar acidity, as indicated by little or no quinacrine staining ([Fig. 2a](#F2){ref-type="fig"} and [Supplementary Fig. 4a](#SD1){ref-type="supplementary-material"}). Kinetic analysis of vacuolar acidity decline using Pho8-SEP/mCherry \[a dual fluorescent protein reporter system in which one copy of vacuolar Pho8 is fused to pH-sensitive super ecliptic pHluorin (SEP, that increases in fluorescence with increasing pH)^[@R18]^, and the other to pH-insensitive mCherry\] revealed that vacuolar acidity declined progressively during the first \~4 mother cell divisions and then remained low through at least 18 divisions ([Fig. 2b](#F2){ref-type="fig"}). However, acidity did not decline to the level observed in cells lacking V-ATPase function ([Fig. 2b](#F2){ref-type="fig"}, ConcA), suggesting that aged cells have not completely lost vacuolar acidity. Because vacuolar acidity decreases prior to mitochondrial dysfunction in ageing cells, we asked whether overexpressing *VMA1* or *VPH2* suppressed mitochondrial dysfunction by preventing vacuolar acidity decline. Indeed, overexpressing *VMA1* or *VPH2* increased vacuolar acidity in ≥70% of aged mother cells (\~18 divisions) ([Fig. 2a](#F2){ref-type="fig"} and [Supplementary Fig. 3b](#SD1){ref-type="supplementary-material"}). Although it is unclear how *VMA1* overexpression increased vacuolar acidity, overexpressing *VPH2* increased levels of assembled V-ATPase at the vacuolar membrane ([Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}).

These results suggest that reduced vacuolar acidity in mother cells leads to the subsequent development of mitochondrial dysfunction. Consistent with this idea, young cells lacking the V-ATPase subunit *VMA2* had reduced ΔΨ and mitochondrial morphology similar to old cells ([Supplementary Fig. 6a](#SD1){ref-type="supplementary-material"}). Additionally, treatment of young cells with the V-ATPase inhibitor concanamycin A caused mitochondrial depolarization just 30 minutes after loss of vacuolar acidity ([Fig. 2c](#F2){ref-type="fig"}, [Supplementary Fig. 6b](#SD1){ref-type="supplementary-material"}). This loss of ΔΨ was followed by mitochondrial fragmentation and aggregation that resembled mitochondrial phenotypes present in old cells. Collectively, these results indicate that vacuolar and mitochondrial function are intimately linked, and suggest that low levels of vacuolar acidity in mother cells cause mitochondrial dysfunction by inducing mitochondrial depolarization that is followed by fragmentation and aggregation. Because mitochondrial function is a critical regulator of lifespan^[@R19]^, we suspected that vacuolar pH would be as well. Consistent with this idea, yeast cells lacking V-ATPase activity have drastically shortened lifespans^[@R20]^ ([Fig. 4c](#F4){ref-type="fig"}). We measured the replicative lifespan (RLS) of wild-type, *VMA1*, and *VPH2* overexpressing strains and found that overexpressing either gene significantly increased both median and maximal RLS ([Fig. 2d](#F2){ref-type="fig"} and [Supplementary Fig. 3c](#SD1){ref-type="supplementary-material"}). These results suggest that vacuolar pH is indeed an important determinant of yeast lifespan.

How might changes in vacuolar pH affect mitochondrial function? The vacuolar proton gradient generated by the V-ATPase is required for efficient protein degradation, and for transport of ions and basic and neutral amino acids into the vacuole for storage^[@R5]^. Blocking vacuolar protein degradation in a pH-independent manner by deleting the vacuolar protease *PEP4*^[@R21]^ did not alter mitochondrial structure or ΔΨ ([Supplementary Fig. 7](#SD1){ref-type="supplementary-material"}). Therefore, we examined whether reduced import of vacuolar metabolites was responsible for mitochondrial dysfunction under conditions of decreased vacuolar acidity. If reduced import of a particular amino acid or ion into the vacuole led to mitochondrial dysfunction, then overexpressing the transporter required for import of that metabolite into the vacuole might suppress mitochondrial dysfunction in cells with a low vacuolar proton gradient. To test this, we reduced the vacuolar proton gradient by treating cells with low concentrations of concanamycin A, and measured mitochondrial ΔΨ with DiOC6 in cells overexpressing individual vacuolar amino acid or ion transporters. Overexpressing most characterized V-ATPase-dependent vacuolar importers^[@R22]--[@R24]^ had no (*NHX1*, *VBA1*, *VBA3*) or little (*VCX1*, *VBA2*) effect on mitochondrial function. However, overexpressing *AVT1*, a neutral amino acid transporter^[@R25]^, prevented mitochondrial dysfunction in 60% of cells ([Supplementary Fig. 8a, b](#SD1){ref-type="supplementary-material"}). This suggests that disrupting proton-dependent neutral amino acid storage in the vacuole causes mitochondrial dysfunction.

We also found that *AVT1* was critical in connecting the vacuole and mitochondria during ageing. Overexpressing *AVT1* prevented alterations in mitochondrial structure and ΔΨ in 63% of aged cells (19 divisions, [Fig. 3a](#F3){ref-type="fig"}), even though vacuolar acidity was reduced in these cells (17 divisions, [Supplementary Fig. 9a](#SD1){ref-type="supplementary-material"}). Conversely, deleting *AVT1* accelerated the development of age-induced mitochondrial dysfunction ([Fig. 3b](#F3){ref-type="fig"}) without affecting the kinetics of vacuolar acidity decline ([Supplementary Fig. 9b](#SD1){ref-type="supplementary-material"}). Deleting *AVT1* also prevented the suppression of mitochondrial dysfunction by *VMA1* and *VPH2* overexpression without affecting vacuolar acidity ([Fig. 3c](#F3){ref-type="fig"} and [Supplementary Fig. 3d](#SD1){ref-type="supplementary-material"}). Collectively, these results suggest that reduced vacuolar acidity in aged cells might cause mitochondrial dysfunction by preventing adequate import of neutral amino acids through the vacuolar transporter Avt1. Importantly, overexpressing or deleting *AVT1* was sufficient to extend or shorten replicative lifespan, respectively ([Fig. 3d](#F3){ref-type="fig"}). This suggests that changes in vacuolar pH modulate lifespan at least in part through regulation of mitochondrial function. The differences in mitochondrial function and lifespan by *AVT1* overexpression or deletion were not as dramatic as when vacuolar pH was increased or decreased (compare [Figure 3](#F3){ref-type="fig"} to 1 and 2), suggesting that substrates of additional V-ATPase-dependent transporters may contribute to age-induced mitochondrial dysfunction caused by reduced vacuolar acidity.

Calorie restriction (CR) extends lifespan in most eukaryotes through conserved nutrient sensing pathways^[@R3]^. In yeast, CR is suggested to function through at least three nutrient sensing kinases: PKA, TOR, and the putative S6 kinase/AKT homolog, Sch9^[@R20],[@R26]^. Reduced activity of any of these kinases mimics CR and extends lifespan. We found that growth in CR carbon sources (0.5% glucose, 0.05% glucose, and 3% glycerol)^[@R26],[@R27]^ increased vacuolar acidity in young cells ([Supplementary Fig. 10](#SD1){ref-type="supplementary-material"}), and prevented the decline of vacuolar acidity in ageing cells ([Fig. 4a](#F4){ref-type="fig"}). CR also suppressed mitochondrial dysfunction in 90% of old cells (21 divisions) in a V-ATPase dependent manner ([Fig. 4b](#F4){ref-type="fig"}).

CR appears to regulate vacuolar acidity through conserved nutrient-sensing pathways because inhibiting PKA, Sch9, or TOR by the lifespan extending mutations *gpa2Δ*, *sch9Δ*, or *tor1Δ*, also prevented the decline of vacuolar acidity and development of mitochondrial dysfunction in ageing cells ([Supplementary Fig. 11a, b](#SD1){ref-type="supplementary-material"})^[@R20],[@R26]^. Consistent with this, constitutively activating the PKA pathway by deleting the Ras GAP, *IRA2*^[@R28]^, reduced vacuolar acidity and accelerated the development of mitochondrial dysfunction in ageing cells ([Supplementary Fig. 11c, d](#SD1){ref-type="supplementary-material"}). Deleting *IRA2* also prevented CR-mediated enhancement of vacuolar acidity and suppression of mitochondrial dysfunction ([Supplementary Fig. 11c, d](#SD1){ref-type="supplementary-material"}). Furthermore, we found that lifespan extension by CR was prevented in a strain lacking V-ATPase activity ([Fig. 4c](#F4){ref-type="fig"}), and conversely, CR did not further extend the lifespan of a strain overexpressing *VMA1* ([Fig. 4d](#F4){ref-type="fig"}). Collectively, these results indicate that vacuolar acidity is a target of CR-regulated nutrient sensing pathways, and suggest that CR suppresses age-induced mitochondrial dysfunction and extends lifespan at least in part by preventing the decline in vacuolar acidity in ageing cells.

In budding yeast, cytokinesis is asymmetric with respect to ageing. Although mother cells age, they produce daughter cells with full lifespan potential, suggesting cellular events that cause ageing are reset in daughter cells^[@R4]^. During our analysis, we discovered a dramatic distinction in vacuolar pH between mother and daughter cells. While vacuolar acidity was reduced in mother cells, high acidity was restored in newborn cells, even in daughters of old mothers ([Fig. 2a, b](#F2){ref-type="fig"} and [Supplementary Fig. 4a, b, c](#SD1){ref-type="supplementary-material"}). This asymmetry required V-ATPase activity, as it was eliminated in *vma2Δ* cells, which lack V-ATPase activity and have constitutively reduced vacuolar acidity ([Supplementary Fig. 4d](#SD1){ref-type="supplementary-material"}). Taking all our results together, the acidity of the vacuole appears critical for re-setting lifespan in new yeast cells, and represents the earliest "rejuvenation" event observed in this organism.

Overall, our results support a model ([Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}) in which a progressive decline in vacuolar acidity during early mother cell divisions limits mitochondrial function and lifespan, and provide a potential mechanism by which amino acid and glucose limitation may converge to regulate lifespan. Somewhat surprisingly, our data suggest that at least in yeast, age-induced mitochondrial dysfunction is not the result of a block in vacuolar protein degradation, but rather due to decreased uptake of neutral amino acids into the vacuolar lumen. How an apparent reduction in neutral amino acid storage leads to a decline in mitochondrial membrane potential remains to be determined, but we speculate that mitochondria-dependent catabolism of excess cytoplasmic amino acids (or their derivatives) places a large burden on proton-dependent mitochondrial carrier proteins^[@R29]^, and in the process, overwhelms mitochondrial ΔΨ. Other metabolites may also contribute to this vacuolar-mitochondrial cross-talk, and the nature of relevant metabolite(s) will be influenced by the cellular growth environment. Given that V-ATPase-coupled amino acid/ion import^[@R5]^ and lifespan extension by reduction of amino acids in food^[@R30]^ are conserved among many organisms, we postulate that our findings in yeast might be applicable to other eukaryotes.

METHODS {#S2}
=======

Strains {#S3}
-------

Yeast strains are listed in [Supplementary Table 1](#SD1){ref-type="supplementary-material"}. All strains are derivatives of *S. cerevisiae* S288c (BY) unless otherwise indicated. One step PCR-mediated gene replacement and epitope tagging were carried out using standard techniques, the previously described template plasmids pRS306, pRS400 KanMX, pKT127, and pBS34^[@R31],[@R32]^, and the newly created template plasmid pKT127-SEP. pBS34 was obtained from the Yeast Resource Center at the University of Washington with permission from Roger Tsien^[@R33]^. Oligos for gene replacement and tagging are listed in [Supplementary Table 2](#SD1){ref-type="supplementary-material"}. Strains expressing empty vector, *VMA1*, *VPH2*, or *AVT1* from a *GPD* promoter integrated into an empty region of chromosome I (199456-199457) were constructed by transformation of parental yeast strains with NotI-digested pAG306-GPD-empty chr I, pAG306-GPD-VMA1 chr I, pAG306-GPD-VPH2 chr I, or pAG306-GPD-AVT1 chr I, respectively. Strains expressing Vma2-GFP were derived from the yeast GFP collection^[@R34]^.

Plasmids {#S4}
--------

pAG306-GPD-empty chr I, pAG306-GPD-VMA1 chr I, pAG306-GPD-VPH2 chr I, and pAG306-GPD-AVT1 chr I were generated in two steps. First, we created pAG306-GPD-ccdB chr I, a plasmid for high expression of genes from the *GPD* promoter that can be integrated into chromosome I (199456-199457) after NotI digestion. We generated pAG306-GPD-ccdB chr I by ligation of a SmaI-digested fusion PCR product that contained two \~500 base pair regions of chromosome I flanking a NotI site into AatII-digested pAG306-GPD-ccdB (Addgene plasmid 14140)^[@R35]^. We generated the fusion PCR product using oligos ChrI PartB SmaI F and ChrI PartA SmaI R to amplify two templates generated by PCR of yeast genomic DNA using oligo pairs ChrI PartA NotI F and ChrI PartA SmaI R, and ChrI PartB SmaI F and ChrI PartB NotI R, respectively. Second, we inserted *VMA1*, *VPH2*, and *AVT1* into pAG306-GPD-ccdB chr I from donor Gateway plasmids pDONR221-VMA1 (HIP ID ScCD00023712), pDONR221-VPH2 (HIP ID ScCD00012560), and pDONR221-AVT1 (HIP ID ScCD00012825) using LR clonase according to manufacturer's instructions (Invitrogen)^[@R36]^. We created pAG306-GPD-empty chr I by digestion of pAG306-GPD-ccdB chr I with HindIII and SpeI to remove the ccdB gene, followed by blunt ended religation of the plasmid after filling in overhangs with T4 DNA polymerase (New England Biolabs).

pKT127-SEP, used for creating in frame C-terminal chromosomal fusions of a gene of interest with super ecliptic pHluorin (SEP), was created by removing GFP from pKT127 by restriction digestion with PacI/AscI and replacing it with PacI/AscI digested SEP generated by PCR of template plasmid pGM87^[@R18]^ using oligos SEP PacI F and SEP AscI R.

Media and cell culture {#S5}
----------------------

Cells were grown exponentially for 15 hours to a maximum density of 5 × 10^6^ cells/ml prior to the initiation of all experiments. Because nutrients and growth phase affected vacuolar and mitochondrial function, extended log-phase growth was necessary to ensure vacuolar and mitochondrial uniformity across the cell population prior to the initiation of all experiments. Cells were cultured in YEPD (1% yeast extract, 2% peptone, 2% glucose) unless otherwise indicated. For CR experiments, cells were cultured in YEP plus the indicated carbon source. Yeast Complete (YC) medium used in the high copy suppressor screen was previously described^[@R37]^. Concanamycin A (Sigma) was added to cultures at a final concentration of 250 or 500 nM as indicated in figure legends.

Culturing and purification of aged MEP cells {#S6}
--------------------------------------------

MEP cells were aged and purified for downstream analysis as previously described with slight modifications^[@R10],[@R38]^. Briefly, 2.5 × 10^7^ cells from a 15 h YEPD log-phase culture were washed twice in phosphate buffered saline, pH 7.4 (PBS) and resuspended in PBS containing 3 mg/ml Sulfa-NHS-LC-Biotin (Pierce) at a final concentration of 2.5 × 10^7^ cells/ml. Cells were incubated for 30 min at room temperature (RT) and then washed twice in PBS and once in YEPD. Biotinylated cells were resuspended in 10 ml YEPD at 2.5 × 10^6^ cells/ml and recovered with shaking for 2 h at 30°C. These cells were used to seed cultures at a density of 2 × 10^4^ biotinylated cells/ml in YEPD. β-estradiol (Sigma) was added to cultures at a final concentration of 1 μM to initiate the MEP and cells were cultured at 30°C for an appropriate time to obtain cells of a desired age (\~1 h for median age 2, 12 h for age 8, 24 h for age 16, 48 h for age 28). Cell densities never exceeded 4 × 10^6^ cells/ml and cells were washed and resuspended in fresh media every 24 h (12 h for CR experiments) to prevent nutrient limitation. At each ageing timepoint, 1 × 10^8^ total cells were harvested for purification, staining, and microscopy analysis.

For live cell purification, cells were washed twice in PBS, resuspended at a density of 2 × 10^8^ cells/ml in 500 μl of PBS, and incubated for 30 min at RT with 25 μl streptavidin-coated magnetic beads (MicroMACS, Miltenyi Biotec). After incubation, cells were washed twice in PBS, resuspended in 8 ml of PBS, and loaded onto a LS MACS column (Miltenyi Biotec) equilibrated with 5 ml of PBS. After gravity flow-through of unlabelled cells and debris, columns were washed twice with 8 ml of PBS. Columns were then removed from the magnetic field and aged cells were eluted by gravity flow with 8 ml of PBS. For cell staining experiments, purified cells were pelleted, resuspended in YEP containing 2 or 0.5% glucose at 2 × 10^6^ cells/ml, and recovered for 1 h at 30°C prior to staining.

For purification of cells after fixation, cells were washed once in PBS and resuspended at 2 × 10^8^ cells/ml and fixed in 500 μl of 4% paraformaldehyde in H~2~O for 15 minutes. Cells were then washed twice in PBS prior to incubation with streptavidin beads at 4°C instead of RT. Additionally, 2 mM EDTA was added to PBS in all fixed cell purification steps to prevent cell clumping.

Labeling and purification of aged non-MEP cells ([Supplementary Fig. 2c](#SD1){ref-type="supplementary-material"}) was conducted exactly as described for MEP cells except that labeled mother cells were purified after 12 hours of log-phase growth, reseeded, and purified a second time after another 12 hours of log-phase growth to obtain 18 division old mother cells. Cells never exceeded a density of 7 × 10^6^ cells/ml.

Fluorescent staining and microscopy {#S7}
-----------------------------------

Quinacrine (Sigma) staining was performed as previously described^[@R39]^. Briefly, 2 × 10^6^ log-phase or purified aged cells were washed once in YEPD + 100 mM HEPES, pH 7.6 and resuspended in 100 μl of the same buffered media containing 200 μM quinacrine. Cells were incubated for 10 min at 30°C and then 5 min on ice. Cells were pelleted and washed twice with ice cold 100 mM HEPES, pH 7.6 + 2% glucose. Cells were resuspended in 100 mM HEPES, pH 7.6 + 2% glucose for imaging. Prior to imaging, cells were kept on ice and all images were obtained within 30 min of staining.

For staining with 5-(and-6)-carboxy-2′,7′-dichlorofluorescein diacetate^[@R11]^ (CDCFDA) (Invitrogen) or 2′,7′-bis (carboxyethyl)-5(6)-carboxyfluorescein^[@R40]^ (BCECF-AM) (Invitrogen), 2 × 10^6^ log-phase or purified aged cells were washed once in YEPD + 100 mM HEPES, pH 7.6 and resuspended in 100 μl of the same buffered media containing 10 μM CDCFDA or 50 μM BCECF. Cells were incubated for 30 min at 30°C and then washed twice with RT 100 mM HEPES, pH 7.6 + 2% glucose. Cells were resuspended in 100 mM HEPES, pH 7.6 + 2% glucose for imaging.

3,3′-dihexyloxacarbocyanine iodide (DiOC~6~) (Invitrogen) staining was carried out according to manufacturer's instructions. Briefly, 2 × 10^6^ log-phase or purified aged cells were washed once in 10 mM HEPES, pH 7.6 + 5% glucose and resuspended in 1 ml of the same buffer containing 175 nM DiOC~6~. Cells were incubated for 15 min at RT and then washed twice with 10 mM HEPES, pH 7.6 + 5% glucose. Cells were resuspended in 10 mM HEPES, pH 7.6 + 5% glucose for imaging. Pho8-SEP imaging was also carried out in DiOC~6~ imaging buffer after incubation of cells for 20 minutes in the buffer. In all live cell experiments, calcofluor (Sigma) staining of bud scars for age determination was carried out by including 5 μg/ml calcofluor in the first post-staining wash step prior to imaging.

For fluorescence microscopy analysis, cells were visualized under 60X oil magnification using a Nikon Eclipse E800 with the appropriate filter set: UV-2E/C DAPI for calcofluor; FITC-HYQ for GFP, SEP, quinacrine, CDCFDA, BCECF, and DiOC~6~; and G-2E/C TRITC for mCherry. Images were acquired with a CoolSNAP HQ^2^ CCD camera (Photometrics) and quantified and processed using Metamorph version 7.1.1.0 imaging software. Cells that exhibited at least four-fold reduction in mean fluorescence intensity, compared to young, wild type cells, were scored as "reduced" in all figures.

Lifespan measurement by micromanipulation {#S8}
-----------------------------------------

RLS was measured by micromanipulation as previously described, except that cells were grown exponentially in YEPD for 15 h instead of 3 h prior to lifespan analysis^[@R10]^.

Membrane Protein Preparation {#S9}
----------------------------

5×10^7^ cells were resuspended in 50 μl B88 buffer (20 mM Hepes, pH 7.2, 150 mM KOAc, 5 mM MgOAc, and 250 mM sorbitol) plus protease inhibitors (leupeptin, pepstatin, PMSF, and aprotinin) and lysed with glass beads for 10 min in a Multi-Tube Vortexer (VWR) at 4°C. 100 μl B88 plus protease inhibitors was added to the sample and the lysate was centrifuged at 500×g for 5 min at 4°C. The supernatant of this spin was centrifuged at 20,000×g for 10 min at 4°C. The membrane pellet was resuspended in 100μl of SDS-lysis buffer (10 mM Tris-HCl, pH 6.8, 100mM NaCl, 1% SDS, 1 mM EDTA, and 1 mM EGTA) plus protease inhibitors. The supernatant of the 20,000×g spin was used as the cytosolic extract.

Imunoblotting {#S10}
-------------

Membrane and cytosolic extracts were mixed with 0.25 volumes of 5× SDS loading buffer (150 mM Tris-HCl, pH 6.8, 15% SDS, 25% glycerol, 0.02% bromophenol blue, 12.5% β-mercaptoethanol) and heated to 37°C for 15 minutes. Aliquots of each sample were resolved on 7% polyacrylamide gels and transferred to nitrocellulose membranes (Invitrogen). Membranes were blocked with 5% non-fat dry milk in PBS-T (137 mM NaCl, 2.7 mM KCl, 10 mM Na~2~HPO~4~, 2 mM KH~2~PO~4~, 0.05% Tween 20, pH 7.4) and then incubated with primary and HRP-conjugated secondary antibodies (Jackson Immunoresearch). Blots were washed in PBS-T after each antibody incubation. Bound peroxidase-conjugated antibodies were detected using the SuperSignal West Pico Chemiluminescent substrate (Pierce). Primary antibodies were anti-Vma2 13D11 (Invitrogen), anti-Pgk1 22C5 (Invitrogen), anti-Pho8 1D3 (Invitrogen), and anti-mCherry Living Colors monoclonal (Clontech).

Screen for high copy suppressors of age-induced mitochondrial dysfunction {#S11}
-------------------------------------------------------------------------

MEP cells expressing Tom70-GFP were individually transformed in 96-well format with 250 high copy 2 μm plasmids from a tiled genomic DNA library^[@R41]^. Each plasmid contained a unique sequence-verified genomic DNA fragment that expressed at least one of 250 genes previously determined to affect mitochondrial morphology when deleted^[@R12],[@R13]^. To identify genes that suppressed age-induced changes in mitochondrial morphology, all 250 plasmid-expressing strains were individually cultured in 5 ml of YEPD at 30°C for 6 h to a density of 2 × 10^4^ cells/ml from overnight-saturated cultures of cells grown in YC-leucine to maintain plasmids. After 6 h in YEPD, β-estradiol was added to cultures at a final concentration of 1 μM to initiate the MEP and cells were cultured at 30°C for an additional 24 h to obtain mother cells with a median age of 16 divisions (n = 15). Cells were collected by centrifugation, fixed with 4% paraformaldehyde, stained with calcofluor, and imaged by fluorescence microscopy for mitochondrial morphology as described above. Plasmid containing strains in which 40% of aged (median age of 16, n = 15) cells exhibited young-cell like tubular mitochondrial morphology were scored as suppressors of age-induced mitochondrial dysfunction. To confirm potential suppressors, each candidate gene was transferred using LR clonase from pDONR221 Gateway entry plasmids from a previously described collection (HIP) into pAG306-GPD-ccdB chr I^[@R36]^. Plasmids were integrated into chromosome I of a Tom70-GFP expressing strain after NotI digestion and strains were aged, purified, and examined by fluorescence microscopy as described above. Positive integrated suppressors (such as *VMA1* and *VPH2*) were confirmed by their ability to maintain young-cell like mitochondrial morphology in at least 70% (n = 30) of aged cells (median age of 17).
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![Age-induced mitochondrial dysfunction is suppressed by *VMA1* overexpression\
Age (divisions) in lower panels of all figures represents exact age for young cells (0--5) and median age for older cells as determined by calcofluor staining of bud scars. n = 30 for all timepoints in all figures. A representative image is shown for each timepoint in all figures. **a**, Mitochondrial morphology in aged cells expressing the mitochondrial outer membrane protein Tom70-GFP. **b**, Mitochondrial membrane potential as indicated by DiOC~6~ staining of aged Tom70-mCherry wild-type (*WT*) and *VMA1* overexpressing cells incubated with or without 500 nM concA for 2 h. Note that DiOC~6~ stains the plasma membrane of aged cells. M = mother cell.](nihms412617f1){#F1}

![Vacuolar acidity is reduced in ageing cells and regulates mitochondrial function and lifespan\
Vacuolar acidity as indicated by (**a**) quinacrine (quin) staining of aged Vph1-mCherry wild-type (*WT*) and *VMA1* overexpressing cells and (**b**) the vacuolar pH reporter Pho8-SEP in cells expressing Pho8-mCherry incubated with or without 500 nM concA for 15 minutes. **c**, DiOC~6~ staining of young cells expressing Tom70-mCherry treated with 500 nM concA for the indicated time. **d**, RLS of wild-type (*WT*) and *VMA1* overexpressing cells by micromanipulation. Median lifespan is indicated. p = 0.0002, Wilcoxon rank-sum test. n = 50 for *WT* and 56 for *VMA1 OE*.](nihms412617f2){#F2}

![Reduced vacuolar acidity causes mitochondrial dysfunction by disrupting amino acid homeostasis\
DiOC~6~ staining of aged Tom70-mCherry *WT*, **(a)** *AVT1* overexpressing and **(b)** *avt1Δ* cells. **c**, Quinacrine and DiOC~6~ staining of aged *WT* and *avt1Δ* cells overexpressing *VMA1*. **d**, RLS of wild-type (*WT*), *avt1Δ,* and *AVT1* overexpressing cells by micromanipulation. Median lifespan is indicated. p = 0.0376 (*WT vs AVT1 OE*), p = 0.0045 (*WT vs avt1Δ*), Wilcoxon rank-sum test. n = 32 for *WT*, 32 for *AVT1 OE*, and 31 for *avt1Δ*.](nihms412617f3){#F3}

![Calorie restriction extends lifespan by regulating vacuolar acidity\
**a**, Quinacrine or **(b)** DiOC~6~ staining of cells expressing **(a)** Vph1-mCherry or **(b)** Tom70-mCherry aged in 2% or 0.5% glucose with or without 500 nM concA for the final 2 h of ageing. RLS of wild-type (*WT*), **(c)** *vma2Δ* and **(d)** *VMA1 OE* cells grown in the absence or presence of CR (0.5% glucose). Median lifespan is indicated. **c**, p \< 0.0001 (*WT vs WT CR*), p = 0.0398 (*vma2Δ vs vma2Δ CR*), p \< 0.0001 (*WT vs vma2Δ*), Wilcoxon rank-sum test. n = 32 for *WT*, 31 for *WT* CR, 60 for *vma2Δ*, and 52 for *vma2Δ CR*. **d**, p \< 0.0001 (*WT vs WT CR*), p \< 0.0001 (*WT vs VMA1 OE*), p = 0.0023 (*WT vs VMA1 OE CR*), p = 0.52 (*WT CR vs VMA1 OE*), p = 0.076 (*VMA1 OE vs VMA1 OE CR*), Wilcoxon rank-sum test. n = 38 for *WT*, 40 for *WT* CR, 36 for *VMA1 OE*, and 38 for *VMA1 OE CR*.](nihms412617f4){#F4}
